收藏切换
Seeking “Taleb Surpass”: Normalization of infection prevention and control of COVID-19 and sustainable growth of technology companies——Empirical evidence from 1907 high technology enterprises in Nanjing
收藏切换
PDF
Science & Technology Review | 2021, 39(14) : 119 - 128
Less
收藏切换
Science & Technology Review | 2021, 39(14): 119-128
Papers
Seeking “Taleb Surpass”: Normalization of infection prevention and control of COVID-19 and sustainable growth of technology companies——Empirical evidence from 1907 high technology enterprises in Nanjing
Full
LUO Lihua1, GAO Yong2, ZHENG Qian1, YANG Yanmei3
Affiliations
    1. Service Center of Nanjing Science and Technology Achievement Transformation, Nanjing 210018, China;
    2. School of Accounting, Nanjing University of Finance&Economics, Nanjing 210023, China;
    3. Party School of the Hai Dian Committee of Communist Party of China, Beijing 100193, China
Published: 2021-07-28 doi: 10.3981/j.issn.1000-7857.2021.14.012
Outline
收藏切换
To achieve the sustainable and high-quality development in the post-epidemic era, it is an important issue for science and technology enterprises to maintain the growth resilience. This paper selects 1907 high-tech enterprises in Nanjing, and in multiple perspectives (e. g., the impact extent, the realistic dilemmas, the policy demands of the normalization of the infection prevention, and the control of COVID-19 in science and technology enterprises) analyzes the actual and potential impacts of the PHEIC. Survey results show that (1) 52.44% science and technology enterprises are deeply affected by the crisis, with the declining revenue as the major challenge and the adverse impact on the new product development as the main barrier for the innovation. (2) In terms of operation, the development of science and technology enterprises is mainly limited by the recruitment of talents, which also leads to the high financial risk. In terms of research and development, the dilemmas appear due to the difficulty in the talent recruitment, the lack of self-help measures in the digitalization and the intelligent transformation, and the high costs of marketing innovative products. (3) There also exists a buffer period for the government's support policies to be fully implemented, which makes the policy demands of the science and technology enterprises unsatisfied. 91.14% of enterprises expect an increase in R&D subsidies. We propose that in the process of the normalization of the epidemic prevention and control, the ways of cultivating and attracting talents for technology enterprises should be updated, and the cooperation of industry, university and research institute should be strengthened. Correspondingly, it is significant to build a dynamic monitoring and technology risk early warning system in the high-tech field f the technology security. Meanwhile, in the reform of the science and technology systems and mechanisms, it is necessary to speed up the construction of the digital government and the scientific and technological innovation environment to promote the science and technology innovation governance system and to modernize the governance capacity.
COVID-19  /  high-tech enterprises  /  sustainable development  /  government policy
LUO Lihua, GAO Yong, ZHENG Qian, YANG Yanmei. Seeking “Taleb Surpass”: Normalization of infection prevention and control of COVID-19 and sustainable growth of technology companies——Empirical evidence from 1907 high technology enterprises in Nanjing[J]. Science & Technology Review, 2021 , 39 (14) : 119 -128 . DOI: 10.3981/j.issn.1000-7857.2021.14.012
Year 2021 volume 39 Issue 14
PDF
469
72
Cite this Article
BibTeX
Article Info
doi: 10.3981/j.issn.1000-7857.2021.14.012
  • Receive Date:2020-12-07
  • Online Date:2021-09-07
  • Published:2021-07-28
Article Data
Affiliations
History
  • Received:2020-12-07
  • Revised:2021-01-18
Affiliations
References
Share
https://castjournals.cast.org.cn/joweb/kjdb/EN/10.3981/j.issn.1000-7857.2021.14.012
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT